AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
Globe Newswire • Tue May 13 2025
BERWYN, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- AscellaHealth has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2025. This prestigious award is presented by Financial Times and Statista Inc., the world-leading statistics portal and industry ranking provider.
BERWYN, Pa., May 13, 2025 (GLOBE NEWSWIRE) – AscellaHealth has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2025. This prestigious award is presented by Financial Times and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on April 2nd, 2025, and can be viewed on the FT.com website.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.